首页> 外文期刊>American Journal of Pathology >Heterogeneity of Endothelial Cells : The Specialized Phenotype of Human High Endothelial VenulesCharacterized by Suppression Subtractive Hybridization
【24h】

Heterogeneity of Endothelial Cells : The Specialized Phenotype of Human High Endothelial VenulesCharacterized by Suppression Subtractive Hybridization

机译:内皮细胞的异质性:人类高内皮小静脉的专门表型的特征在于抑制性消减杂交

获取原文
获取原文并翻译 | 示例
       

摘要

High endothelial venules (HEVs) are specialized postcapillary venules, found in lymphoid organs and chronically inflamed tissues, that support high levels of lymphocyte extravasation from the blood. Molecular characterization of HEV endothelial cells (HEVECs) has been hampered by difficulties in their purification and in vitro maintenance. To overcome these limitations, we developed a strategy combining the use of freshly purified HEVECs (~98% positive for the HEV-specific marker MECA-79) and the recently described polymerase chain reaction (PCR)-based cDNA subtraction cloning procedure called suppression subtractive hybridization (SSH). Subtracted probes prepared by SSH from small amounts of total RNA were used to screen a HEVEC cDNA library. This resulted in cloning of 22 cDNAs preferentially expressed in HEVECs, which encode the promiscuous chemokine receptor DARC, mitochondrial components, and matricellular proteins. The latter included hevin, thrombospondin-1, and mac25/IGFBP-rP1, which is a secreted growth factor-binding protein previously found to accumulate specifically in tumor blood vessels. Biochemical and histochemical analysis confirmed the identification of mac25 and DARC as novel markers of the HEVECs. Ultrastructural immunolocalization revealed a noticeable association of mac25 and MECA-79 antigens with microvillous processes near the endothelial cell junctions, suggesting a role for mac25 in the control of lymphocyte emigration. This study shows that PCR-based SSH is useful for cloning of differentially expressed genes in very small samples.
机译:高内皮小静脉(HEVs)是专门的毛细血管后小静脉, 存在于淋巴器官和慢性发炎的组织中, 支持从血液中大量渗出淋巴细胞。 HEV内皮细胞(supve)的分子表征 受到纯化和 体外维护困难的困扰。为了克服这些局限性,我们开发了一种 策略,该策略结合使用新鲜纯化的HEVEC(HEV特异性标记MECA-79的阳性率约为98%) > 描述了基于聚合酶链反应(PCR)的cDNA减法 克隆程序,称为抑制消减杂交 (SSH)。通过SSH从少量总RNA中扣除的探针用于筛选HEVEC cDNA文库。这导致克隆了HEVEC中优先表达的22个cDNA,这些cDNA编码混杂的趋化因子受体DARC,线粒体sups组分和基质细胞蛋白。后者包括 hevin,thrombospondin-1和mac25 / IGFBP-rP1,这是一种分泌的 生长因子结合蛋白,以前发现它会积累 特别是在肿瘤血管中。生化和组织化学 分析证实了mac25和DARC的鉴定是HEVEC的新型 标记。超微结构免疫定位揭示了 mac25和MECA-79抗原与内皮细胞连接附近的 微毛过程明显相关, 暗示了mac25在小鼠中的作用。 该研究表明基于PCR的SSH可用于克隆非常小的样品中 差异表达的基因。

著录项

  • 来源
    《American Journal of Pathology》 |1999年第6期|2043-2055|共13页
  • 作者单位

    From the Institut de Pharmacologie et de Biologie Structurale du CNRS,Toulouse, France;

    and the Laboratory for Immunohistochemistry and Immunopathology,Institute of Pathology, University of Oslo, The National Hospital, Oslo, Norway;

    and the Laboratory for Immunohistochemistry and Immunopathology,Institute of Pathology, University of Oslo, The National Hospital, Oslo, Norway;

    and the Laboratory for Immunohistochemistry and Immunopathology,Institute of Pathology, University of Oslo, The National Hospital, Oslo, Norway;

    and the Laboratory for Immunohistochemistry and Immunopathology,Institute of Pathology, University of Oslo, The National Hospital, Oslo, Norway;

    From the Institut de Pharmacologie et de Biologie Structurale du CNRS,Toulouse, France;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号